Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid is a naturally occurring glycosaminoglycan found in various tissues, including synovial fluid, skin, and connective tissue. It functions as a lubricant and a shock absorber. It is available in multiple formulations for different routes of administration.
## Primary Indications
* **Intra-articular:** Osteoarthritis of the knee.
* **Ophthalmic:** Ophthalmic surgery (e.g., cataract surgery, corneal transplantation), dry eye disease.
* **Topical:** Wound healing, skin hydration.
* **Intradermal/Subcutaneous (Dermal Fillers):** Aesthetic correction of facial wrinkles and folds.
## Adult Dosing
* **Intra-articular (Osteoarthritis of the Knee):**
* Formulations vary significantly. Common regimens include:
* Single injection: 20 mg (2 mL) injected intra-articularly once.
* Multiple injections: 20 mg (2 mL) injected intra-articularly once weekly for 3 to 5 weeks.
* Follow specific product labeling and local protocol. Some protocols may recommend a course of injections regardless of the specific product.
* **Ophthalmic (Viscosurgical Devices for Surgery):**
* Typically administered by the surgeon during ophthalmic procedures. Dosing is procedure-dependent.
* **Ophthalmic (Dry Eye Disease):**
* 1-2 drops instilled into the affected eye(s) as needed, or as directed by a healthcare professional. Concentrations typically range from 0.1% to 0.4%.
* **Topical (Wound Healing/Skin Hydration):**
* Apply to affected area as directed by the product or healthcare professional. Concentrations and frequency vary widely.
* **Intradermal/Subcutaneous (Dermal Fillers):**
* Dosing is highly variable and depends on the area treated, desired correction, and specific product formulation. Administered by trained healthcare professionals.
## Pediatric Dosing
Dosing for hyaluronic acid in pediatric populations is generally not established for most indications, particularly for intra-articular use. Ophthalmic formulations for dry eye may be used off-label in children, but specific dosing guidance is limited and should be determined by a healthcare professional.
## Dose Adjustments
No specific dose adjustments are typically required based on renal or hepatic impairment for commonly used formulations.
## Contraindications
* Known hypersensitivity to hyaluronic acid or any component of the formulation.
* Infection at or near the injection site.
* Severe skin conditions at the application/injection site (topical/intra-articular/dermal fillers).
## Adverse Effects
* **Intra-articular:** Local pain, swelling, stiffness, joint effusion, transient inflammatory reactions, arthralgia, headache, dizziness.
* **Ophthalmic:** Transient blurred vision, eye irritation, stinging, burning, redness, foreign body sensation.
* **Topical:** Local skin irritation, redness, itching.
* **Intradermal/Subcutaneous (Dermal Fillers):** Bruising, swelling, redness, pain, tenderness at the injection site; nodules, lumps, or granulomas (rare).
## Key Drug Interactions
No significant drug interactions are well-established for hyaluronic acid when used as directed for its primary indications. However, concurrent use of other intra-articular injections or topical medications in the same area should be discussed with a healthcare provider.
## Monitoring
* **Intra-articular:** Monitor for signs and symptoms of infection (fever, chills, increased joint pain, swelling, redness) and inflammatory reactions.
* **Ophthalmic:** Monitor for persistent or worsening eye irritation, pain, or vision changes.
* **Topical/Dermal Fillers:** Monitor for signs of infection or adverse reactions at the site of application/injection.
## Clinical Pearls
* Hyaluronic acid formulations for intra-articular injection are typically administered as a series of injections, though some single-injection products exist. The number of injections and timing depend on the specific product and clinical protocol.
* Proper aseptic technique is crucial for intra-articular and ophthalmic administration to prevent infection.
* For ophthalmic use, patients should be advised to avoid rubbing their eyes after instillation.
* Dermal filler products are intended for aesthetic purposes and should only be administered by qualified and experienced medical professionals.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the current prescribing information and relevant clinical guidelines for specific drug products and patient care decisions.